Adagio Medical (ADGM) announces $19M upfront, $31M potential warrant proceeds in private placement

Adagio Medical Holdings, Inc.

Upfront proceeds ~$19M from 9.79M shares/pre-funded warrants at $1.9403 combined; Perceptive Advisors affiliate invests $4.25M.
Warrants (Tranche A/B/C) exercisable at $1.71/share for up to ~18M shares; expire based on FULCRUM-VT results, FDA approvals.
Proceeds used for working capital and advancement of cardiac ablation clinical and product development activities.
Private placement led by existing investor Perceptive Advisors; Piper Sandler sole placement agent; closing expected week of Oct 13.

item 1.01 item 3.02 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Adagio Medical Holdings, Inc. issued 9,792,506 shares of common stock to accredited investors for $1.9403 per Share.

Security: common stock
Shares: 9,792,506 shares
Purchaser: accredited investors
Consideration: $1.9403 per Share

Exact text from the filing

will be accompanied by one Tranche A Warrant, one Tranche B Warrant and one Tranche C Warrant. The combined purchase price of each Share and accompanying Milestone Warrants is $1.9403 and (which includes $0.2303 for the Milestone Warrants sold with each Share in accordance with the rules and regulations of The Nasdaq Stock Market LLC). The combined purchase

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Adagio Medical Holdings, Inc. issued pre-funded warrants in lieu of shares of Common Stock of warrant to accredited investors for $1.9402 per Pre-Funded Warrant and $0.0001 exercise price.

Security: warrant
Shares: pre-funded warrants in lieu of shares of Common Stock
Purchaser: accredited investors
Consideration: $1.9402 per Pre-Funded Warrant and $0.0001 exercise price

Exact text from the filing

whereby the Company will issue and sell to the Purchasers in a private placement (the “Private Placement”): (i) 9,792,506 shares (the “Shares”) of its common stock, par value $0.0001 per share (the “Common Stock”), or pre-funded warrants (the “Pre-Funded Warrants”) to purchase shares of Common Stock in lieu thereof, and (ii) accompanying (a) Tranche A Warrants

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Adagio Medical Holdings, Inc. issued 6,012,943 shares of Common Stock of warrant to accredited investors for $1.71 per share exercise price.

Security: warrant
Shares: 6,012,943 shares of Common Stock
Purchaser: accredited investors
Consideration: $1.71 per share exercise price

Exact text from the filing

by reference herein. Terms of the Pre-Funded Warrants and Milestone Warrants Each Milestone Warrant is exercisable for one share of Common Stock at an exercise price of $1.71 per share. The Milestone Warrants will expire upon the earlier of (i) five years from the date of issuance or (ii) (a) for the Tranche A Warrants, the date that is thirty (30)

View on SEC.gov

25 equity issuances filed in the last 30 days. Browse all equity issuances →

Adagio Medical Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-099535

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.